AKT1 and renal cell carcinoma: The PI3K-Akt pathway, which regulates cell proliferation, differentiation, and survival [38], was activated, as was the TGF-β pathway, with enrichment of tumor-related pathways, including those related to proteoglycans in cancer and renal cell carcinoma.